Gildardo Rivera | Medicinal chemistry | Editorial Board Member

Published on | Editorial Board by World Top Scientists

Editorial Board Member

Gildardo Rivera
Instituto Politecnico Nacional

Gildardo Rivera
Affiliation Instituto Politecnico Nacional
Country Mexico
Scopus ID 24333214400
Documents 249
Citations 3,497
h-index 29
Subject Area Medicinal chemistry
Event World Top Scientist Awards
ORCID 0000-0001-9842-4167

Gildardo Rivera is a Mexican researcher recognized for his contributions to medicinal chemistry and interdisciplinary biomedical research. His academic career is associated with the Instituto Politecnico Nacional, where he has contributed to scientific development through extensive publications. His work primarily focuses on drug discovery, antimicrobial resistance, and computational chemistry approaches. Rivera’s scholarly output has achieved global visibility through citation impact and collaborative research networks [1].

Abstract

This article presents a structured academic overview of Gildardo Rivera’s contributions to medicinal chemistry and pharmaceutical sciences. It highlights his research output, citation metrics, and institutional affiliations within a global scientific context. The analysis integrates bibliometric indicators with qualitative evaluation of research domains. It aims to provide a comprehensive profile relevant for academic recognition and editorial positions.

Keywords

Medicinal chemistry, drug discovery, computational biology, antimicrobial resistance, pharmacological research, scientific publications, bibliometrics, molecular modeling, interdisciplinary science, pharmaceutical innovation.

Introduction

Medicinal chemistry plays a central role in modern healthcare innovation by enabling the development of targeted therapeutic agents. Researchers such as Gildardo Rivera contribute significantly through experimental and computational methodologies. His work integrates chemical synthesis, biological evaluation, and in silico modeling approaches. These interdisciplinary efforts align with global priorities in combating infectious and chronic diseases.

Research Profile

Rivera’s academic profile is characterized by sustained research productivity and international collaboration networks. His affiliation with Instituto Politecnico Nacional reflects strong institutional support for scientific advancement. The researcher has produced over two hundred indexed publications across high-impact journals. His work demonstrates a balance between theoretical modeling and applied biomedical research outcomes.

Research Contributions

The contributions of Rivera encompass antimicrobial drug discovery, anticancer studies, and computational screening methodologies. His studies frequently address global challenges such as antibiotic resistance and parasitic diseases. The integration of molecular docking and experimental validation strengthens the reliability of findings. These contributions have influenced ongoing research directions in pharmaceutical sciences.

Publications

Rivera’s publication record includes peer-reviewed articles focusing on drug design, pharmacological evaluation, and environmental health studies. His work spans journals such as Molecules, Medicinal Chemistry, and Environmental Science publications. The research demonstrates methodological diversity and interdisciplinary collaboration. These publications contribute to both theoretical frameworks and practical applications in medicinal chemistry.

Research Impact

The research impact of Rivera is reflected through citation metrics and academic influence across disciplines. With thousands of citations and a significant h-index, his work has achieved recognition in scientific communities. His publications support advancements in drug discovery and public health research. This impact underscores the relevance of his contributions in global biomedical science.

Award Suitability

Rivera’s academic achievements align with the criteria for international scientific awards and editorial roles. His consistent output and interdisciplinary research strengthen his professional standing. Recognition through global platforms highlights his contribution to advancing medicinal chemistry. Such credentials support his suitability for editorial board memberships and scientific honors.

Conclusion

The academic profile of Gildardo Rivera reflects a comprehensive contribution to medicinal chemistry and biomedical research. His work integrates experimental and computational techniques to address complex health challenges. The consistency of his scholarly output demonstrates sustained academic engagement. Overall, his profile supports recognition within global scientific and editorial communities.

References

  1. Blanco-Torres, E. C., Rivera, G., Delgado-Maldonado, T., Ortiz-Pérez, E., Paz-González, A. D., Martínez-Vázquez, A. V., et al. (2026). Food crops (Poaceae, Solanaceae, and Fabaceae) with anticancer nutraceutical prospects: A review of plant extracts. Molecules.
    https://doi.org/10.3390/molecules31122126
  2. Rivera, G., Navarrete-Carriola, D. V., De Angelis, L., Paz-González, A. D., Martínez-Vázquez, A. V., Ortiz-Pérez, E., et al. (2026). Biological evaluation of esters of 4-carboxylate-1,2,3-triazine as anti-Mycobacterium tuberculosis agents. Molecules.
    https://doi.org/10.3390/molecules31121993
  3. Paz-González, A. D., Rivera, G., Toledo-Bravo, K. N., Licea-Herrera, J. I., Lizarazo-Ortega, C., Bocanegra-García, V., et al. (2026). Antibiotic risk assessment in agricultural soil from Tamaulipas, Mexico. Journal of Environmental Science and Health, Part B.
    https://doi.org/10.1080/03601234.2026.2641965
  4. Blanco-Torres, E. C., Rivera, G., Delgado-Maldonado, T., Ortiz-Pérez, E., Paz-González, A. D., Martínez-Vázquez, A. V., et al. (2026). Anticancer potential of Cucurbitaceae, Brassicaceae, Liliaceae and Chenopodiaceae: A review of in vitro evidence. Molecules.
    https://doi.org/10.3390/molecules31111902
  5. Delgado-Maldonado, T., Moreno-Rodríguez, A., González-Morales, L. D., Flores-Villegas, A. L., Rodríguez-González, J., Rodríguez-Páez, L., et al. (2024). Design, synthesis, and evaluation of 1,3,4-oxadiazoles as anti-Trypanosoma cruzi agents. ChemMedChem.
    https://doi.org/10.1002/cmdc.202400241

Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Published on | Editorial Board by World Top Scientists

Prof. Dr. Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Assistant Professor | Sandip Institute of Pharmaceutical Sciences | India

Dr. Meghraj Vivekanand Suryawanshi is an accomplished Associate Professor and Training & Placement Coordinator at the Sandip Institute of Pharmaceutical Sciences, Nashik, specializing in pharmaceutics. He holds a Ph.D. in Pharmaceutics from Jaipur National University, an M.Pharm in Pharmaceutics from R.C. Patel Institute of Pharmaceutical Education and Research, a B.Pharm from Sinhgad Institutes of Pharmaceutical Sciences, and an MBA in Hospital Administration. Dr. Suryawanshi has extensive professional experience, serving as a Ph.D. research scholar, Assistant Professor at multiple institutions, and co-founder and CTO of AllWell Nutritech LLP, where he contributed to start-up incubation and entrepreneurial initiatives. He has supervised numerous undergraduate and postgraduate students and actively coordinated academic and administrative programs including training and placement, entrepreneurship, library management, and examination coordination. His research focuses on advanced drug delivery systems, formulation development, and pharmaceutical technology, with a significant body of publications contributing to national and international journals. Dr. Suryawanshi has also engaged in editorial responsibilities and professional memberships that support scholarly exchange and innovation in the pharmaceutical sciences. Recognized for his dedication to research, education, and mentorship, he has been instrumental in fostering academic excellence, student development, and industry collaboration, demonstrating leadership, scientific rigor, and a commitment to advancing the field of pharmaceutics at both institutional and broader professional levels.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Suryawanshi, I., Srinidhi, S., Singh, S., Kalia, R., Kunchala, R. K., Mudavath, S. L., …. (2021). Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting. Materials Today Communications, 26, 102144.

2. Patil, S. M., Suryawanshi, M. V., Chandanshive, V. V., Kurade, M. B., Govindwar, S. P., …. (2020). Regeneration of textile wastewater deteriorated microbial diversity of soil microcosm through bioaugmentation. Chemical Engineering Journal, 380, 122533.

3. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative disorders. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(6), 3803–3818.

4. Bhagat, D. S., Suryawanshi, I. V., Gurnule, W. B., Sawant, S. S., & Chavan, P. B. (2021). Greener synthesis of CuO nanoparticles for enhanced development of latent fingerprints. Materials Today: Proceedings, 36, 747–750.

5. Suryawanshi, I., Kalia, R., Kunchala, R. K., Mudavath, S. L., & Naidu, B. S. (2022). Detection of latent fingerprints using luminescent Gd0.95Eu0.05PO4 nanorods. Journal of Rare Earths, 40(4), 572–578.